Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015, Article ID 541984, 8 pages
http://dx.doi.org/10.1155/2015/541984
Review Article

New Insights into the Function of the Immunoproteasome in Immune and Nonimmune Cells

1Division of Inflammation Research, Center for Molecular Medicine, Jichi Medical University School of Medicine, 3311-1 Yakushiji, Shimotsuke, Tochigi 329-0498, Japan
2Department of Pathology, The Johns Hopkins School of Medicine, Ross 656, 720 Rutland Avenue, Baltimore, MD 20205, USA
3Department of Clinical Laboratory Science, Faculty of Medical Science, Teikyo University, 2-11-1 Kaga, Itabashi, Tokyo 173-8605, Japan

Received 10 July 2015; Accepted 10 September 2015

Academic Editor: Darren R. Flower

Copyright © 2015 Hiroaki Kimura et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Tanaka, “Role of proteasomes modified by interferon-gamma in antigen processing,” Journal of Leukocyte Biology, vol. 56, no. 5, pp. 571–575, 1994. View at Google Scholar · View at Scopus
  2. P.-M. Kloetzel and F. Ossendorp, “Proteasome and peptidase function in MHC-class-I-mediated antigen presentation,” Current Opinion in Immunology, vol. 16, no. 1, pp. 76–81, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Tanaka, “The proteasome: overview of structure and functions,” Proceedings of the Japan Academy. Series B: Physical and Biological Sciences, vol. 85, no. 1, pp. 12–36, 2009. View at Publisher · View at Google Scholar
  4. A. Ichihara and K. Tanaka, “Roles of proteasomes in cell growth,” Molecular Biology Reports, vol. 21, no. 1, pp. 49–52, 1995. View at Publisher · View at Google Scholar · View at Scopus
  5. H. J. Fehling, W. Swat, C. Laplace et al., “MHC class I expression in mice lacking the proteasome subunit LMP-7,” Science, vol. 265, no. 5176, pp. 1234–1237, 1994. View at Publisher · View at Google Scholar · View at Scopus
  6. A. J. A. M. Sijts, S. Standera, R. E. M. Toes et al., “MHC class I antigen processing of an adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cells,” The Journal of Immunology, vol. 164, no. 9, pp. 4500–4506, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. W. Chen, C. C. Norbury, Y. Cho, J. W. Yewdell, and J. R. Bennink, “Immunoproteasomes shape immunodominance hierarchies of antiviral CD8+ T cells at the levels of T cell repertoire and presentation of viral antigens,” The Journal of Experimental Medicine, vol. 193, no. 11, pp. 1319–1326, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. P.-M. Kloetzel, “Antigen processing by the proteasome,” Nature Reviews Molecular Cell Biology, vol. 2, no. 3, pp. 179–187, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. I. Shachar and N. Karin, “The dual roles of inflammatory cytokines and chemokines in the regulation of autoimmune diseases and their clinical implications,” Journal of Leukocyte Biology, vol. 93, no. 1, pp. 51–61, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Muchamuel, M. Basler, M. A. Aujay et al., “A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis,” Nature Medicine, vol. 15, no. 7, pp. 781–787, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Basler, M. Dajee, C. Moll, M. Groettrup, and C. J. Kirk, “Prevention of experimental colitis by a selective inhibitor of the immunoproteasome,” Journal of Immunology, vol. 185, no. 1, pp. 634–641, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Basler, S. Mundt, T. Muchamuel et al., “Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis,” EMBO Molecular Medicine, vol. 6, no. 2, pp. 226–238, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. H. J. Kimura, C. Y. Chen, S.-C. Tzou et al., “Immunoproteasome overexpression underlies the pathogenesis of thyroid oncocytes and primary hypothyroidism: studies in humans and mice,” PLoS ONE, vol. 4, no. 11, article e7857, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. Cui, S. M. Hwang, and A. V. Gomes, “Identification of the immunoproteasome as a novel regulator of skeletal muscle differentiation,” Molecular and Cellular Biology, vol. 34, no. 1, pp. 96–109, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Kitamura, Y. Maekawa, H. Uehara et al., “A mutation in the immunoproteasome subunit PSMB8 causes autoinflammation and lipodystrophy in humans,” The Journal of Clinical Investigation, vol. 121, no. 10, pp. 4150–4160, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. I. E. Keller, O. Vosyka, S. Takenaka et al., “Regulation of immunoproteasome function in the lung,” Scientific Reports, vol. 5, Article ID 10230, 2015. View at Publisher · View at Google Scholar
  17. J. Haorah, D. Heilman, C. Diekmann et al., “Alcohol and HIV decrease proteasome and immunoproteasome function in macrophages: implications for impaired immune function during disease,” Cellular Immunology, vol. 229, no. 2, pp. 139–148, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Frisan, V. Levitsky, and M. G. Masucci, “Variations in proteasome subunit composition and enzymatic activity in B-lymphoma lines and normal B cells,” International Journal of Cancer, vol. 88, no. 6, pp. 881–888, 2000. View at Google Scholar · View at Scopus
  19. P. Leone, M. Di Tacchio, S. Berardi et al., “Dendritic cell maturation in HCV infection: altered regulation of MHC class i antigen processing-presenting machinery,” Journal of Hepatology, vol. 61, no. 2, pp. 242–251, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Tanaka, “Molecular biology of proteasomes,” Molecular Biology Reports, vol. 21, no. 1, pp. 21–26, 1995. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Unno, T. Mizushima, Y. Morimoto et al., “The structure of the mammalian 20S proteasome at 2.75 Å resolution,” Structure, vol. 10, no. 5, pp. 609–618, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Groll, L. Ditzel, J. Löwe et al., “Structure of 20S proteasome from yeast at 2.4 Å resolution,” Nature, vol. 386, no. 6624, pp. 463–471, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. G. N. DeMartino and C. A. Slaughter, “The proteasome, a novel protease regulated by multiple mechanisms,” Journal of Biological Chemistry, vol. 274, no. 32, pp. 22123–22126, 1999. View at Publisher · View at Google Scholar · View at Scopus
  24. V. Ortiz-Navarrete, A. Seelig, M. Gernold, S. Frentzel, P. M. Kloetzel, and G. J. Hämmerling, “Subunit of the ‘20S’ proteasome (multicatalytic proteinase) encoded by the major histocompatibility complex,” Nature, vol. 353, no. 6345, pp. 662–664, 1991. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Glynne, S. H. Powis, S. Beck, A. Kelly, L.-A. Kerr, and J. Trowsdale, “A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC,” Nature, vol. 353, no. 6342, pp. 357–360, 1991. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Kelly, S. H. Powis, R. Glynne, E. Radley, S. Beck, and J. Trowsdale, “Second proteasome-related gene in the human MHC class II region,” Nature, vol. 353, no. 6345, pp. 667–668, 1991. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Realini, W. Dubiel, G. Pratt, K. Ferrell, and M. Rechsteiner, “Molecular cloning and expression of a γ-interferon-inducible activator of the multicatalytic protease,” The Journal of Biological Chemistry, vol. 269, no. 32, pp. 20727–20732, 1994. View at Google Scholar · View at Scopus
  28. J. Y. Ahn, N. Tanahashi, K. Akiyama et al., “Primary structures of two homologous subunits of PA28, a γ-interferon-inducible protein activator of the 20S proteasome,” FEBS Letters, vol. 366, no. 1, pp. 37–42, 1995. View at Publisher · View at Google Scholar · View at Scopus
  29. N. Tanahashi, K.-Y. Yokota, J. Y. Ahn et al., “Molecular properties of the proteasome activator PA28 family proteins and γ-interferon regulation,” Genes to Cells, vol. 2, no. 3, pp. 195–211, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. J. A. Nathan, V. Spinnenhirn, G. Schmidtke, M. Basler, M. Groettrup, and A. L. Goldberg, “Immuno- and constitutive proteasomes do not differ in their abilities to degrade ubiquitinated proteins,” Cell, vol. 152, no. 5, pp. 1184–1194, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. M. E. Arellano-Garcia, K. Misuno, S. D. Tran, and S. Hu, “Interferon-γ induces immunoproteasomes and the presentation of MHC I-associated peptides on human salivary gland cells,” PLoS ONE, vol. 9, no. 8, Article ID e102878, 2014. View at Publisher · View at Google Scholar · View at Scopus
  32. P. M. Kloetzel, “Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII,” Nature Immunology, vol. 5, no. 7, pp. 661–669, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. M. D. Robek, M. L. Garcia, B. S. Boyd, and F. V. Chisari, “Role of immunoproteasome catalytic subunits in the immune response to hepatitis B virus,” Journal of Virology, vol. 81, no. 2, pp. 483–491, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Z. Kincaid, J. W. Che, I. York et al., “Mice completely lacking immunoproteasomes show major changes in antigen presentation,” Nature Immunology, vol. 13, no. 2, pp. 129–135, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. E. Opitz, A. Koch, K. Klingel et al., “Impairment of immunoproteasome function by beta5i/lmp7 subunit deficiency results in severe enterovirus myocarditis,” PLoS Pathogens, vol. 7, no. 9, Article ID e1002233, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. S. E. Hensley, D. Zanker, B. P. Dolan et al., “Unexpected role for the immunoproteasome subunit LMP2 in antiviral humoral and innate immune responses,” Journal of Immunology, vol. 184, no. 8, pp. 4115–4122, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. F. Novelli and J.-L. Casanova, “The role of IL-12, IL-23 and IFN-γ in immunity to viruses,” Cytokine and Growth Factor Reviews, vol. 15, no. 5, pp. 367–377, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. E.-C. Shin, U. Seifert, T. Kato et al., “Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection,” The Journal of Clinical Investigation, vol. 116, no. 11, pp. 3006–3014, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Basler, U. Beck, C. J. Kirk, and M. Groettrup, “The antiviral immune response in mice devoid of immunoproteasome activity,” Journal of Immunology, vol. 187, no. 11, pp. 5548–5557, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. I. Gutcher and B. Becher, “APC-derived cytokines and T cell polarization in autoimmune inflammation,” Journal of Clinical Investigation, vol. 117, no. 5, pp. 1119–1127, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. C. B. Schmidt-Weber, M. Akdis, and C. A. Akdis, “TH17 cells in the big picture of immunology,” The Journal of Allergy and Clinical Immunology, vol. 120, no. 2, pp. 247–254, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. P. J. Barnes and M. Karin, “Nuclear factor-κB—a pivotal transcription factor in chronic inflammatory diseases,” The New England Journal of Medicine, vol. 336, no. 15, pp. 1066–1071, 1997. View at Publisher · View at Google Scholar · View at Scopus
  43. P. P. Tak and G. S. Firestein, “NF-kappaB: a key role in inflammatory diseases,” The Journal of Clinical Investigation, vol. 107, no. 1, pp. 7–11, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. P. Libby, “Inflammation in atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 9, pp. 2045–2051, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. J.-L. Davignon, M. Hayder, M. Baron et al., “Targeting monocytes/macrophages in the treatment of rheumatoid arthritis,” Rheumatology, vol. 52, no. 4, Article ID kes304, pp. 590–598, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. K. W. Kalim, M. Basler, C. J. Kirk, and M. Groettrup, “Immunoproteasome subunit LMP7 deficiency and inhibition suppresses Th1 and Th17 but enhances regulatory T cell differentiation,” Journal of Immunology, vol. 189, no. 8, pp. 4182–4193, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Maldonado, R. J. Kapphahn, M. R. Terluk et al., “Immunoproteasome deficiency modifies the alternative pathway of NFkappaB signaling,” PLoS ONE, vol. 8, no. 2, Article ID e56187, 2013. View at Publisher · View at Google Scholar · View at Scopus
  48. J. Reis, X. Q. Guan, A. F. Kisselev et al., “LPS-induced formation of immunoproteasomes: TNF-α and nitric oxide production are regulated by altered composition of proteasome-active sites,” Cell Biochemistry and Biophysics, vol. 60, no. 1-2, pp. 77–88, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. Y. K. Ho, P. Bargagna-Mohan, M. Wehenkel, R. Mohan, and K.-B. Kim, “LMP2-specific inhibitors: chemical genetic tools for proteasome biology,” Chemistry and Biology, vol. 14, no. 4, pp. 419–430, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Reidlinger, A. M. Pike, P. J. Savory, R. Z. Murray, and A. J. Rivett, “Catalytic properties of 26 S and 20 S proteasomes and radiolabeling of MB1, LMP7, and C7 subunits associated with trypsin-like and chymotrypsin-like activities,” The Journal of Biological Chemistry, vol. 272, no. 40, pp. 24899–24905, 1997. View at Publisher · View at Google Scholar · View at Scopus
  51. P. Caturegli, M. Hejazi, K. Suzuki et al., “Hypothyroidism in transgenic mice expressing IFN-gamma in the thyroid,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 4, pp. 1719–1724, 2000. View at Publisher · View at Google Scholar · View at Scopus
  52. H. Kimura, M. Kimura, W. H. Westra, N. R. Rose, and P. Caturegli, “Increased thyroidal fat and goitrous hypothyroidism induced by interferon-gamma,” International Journal of Experimental Pathology, vol. 86, no. 2, pp. 97–106, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. Y. Nagayama, M. Nakahara, M. Shimamura, I. Horie, K. Arima, and N. Abiru, “Prophylactic and therapeutic efficacies of a selective inhibitor of the immunoproteasome for Hashimoto's thyroiditis, but not for Graves' hyperthyroidism, in mice,” Clinical & Experimental Immunology, vol. 168, no. 3, pp. 268–273, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Volkov, S. Hagner, S. Löser et al., “Beta5i subunit deficiency of the immunoproteasome leads to reduced Th2 response in OVA induced acute asthma,” PLoS ONE, vol. 8, no. 4, Article ID e60565, 2013. View at Publisher · View at Google Scholar · View at Scopus
  55. L. Zu, D. Bedja, K. Fox-Talbot et al., “Evidence for a role of immunoproteasomes in regulating cardiac muscle mass in diabetic mice,” Journal of Molecular and Cellular Cardiology, vol. 49, no. 1, pp. 5–15, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. Z. Hu, H. Wang, I. H. Lee et al., “PTEN inhibition improves muscle regeneration in mice fed a high-fat diet,” Diabetes, vol. 59, no. 6, pp. 1312–1320, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. K. Arima, A. Kinoshita, H. Mishima et al., “Proteasome assembly defect due to a proteasome subunit beta type 8 (PSMB8) mutation causes the autoinflammatory disorder, Nakajo-Nishimura syndrome,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 36, pp. 14914–14919, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. A. K. Agarwal, C. Xing, G. N. DeMartino et al., “PSMB8 encoding the beta5i proteasome subunit is mutated in joint contractures, muscle atrophy, microcytic anemia, and panniculitis-induced lipodystrophy syndrome,” The American Journal of Human Genetics, vol. 87, no. 6, pp. 866–872, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Garg, M. D. Hernandez, A. B. Sousa et al., “An autosomal recessive syndrome of joint contractures, muscular atrophy, microcytic anemia, and panniculitis-associated lipodystrophy,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 9, pp. E58–E63, 2010. View at Publisher · View at Google Scholar · View at Scopus
  60. Y. Liu, Y. Ramot, A. Torrelo et al., “Mutations in proteasome subunit β type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity,” Arthritis and Rheumatism, vol. 64, no. 3, pp. 895–907, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. K. Kunimoto, A. Kimura, K. Uede et al., “A new infant case of nakajo-nishimura syndrome with a genetic mutation in the immunoproteasome subunit: an overlapping entity with JMP and CANDLE syndrome related to PSMB8 mutations,” Dermatology, vol. 227, no. 1, pp. 26–30, 2013. View at Publisher · View at Google Scholar · View at Scopus
  62. G. Y. Deng, A. Muir, N. K. Maclaren, and J.-X. She, “Association of LMP2 and LMP7 genes within the major histocompatibility complex with insulin-dependent diabetes mellitus: population and family studies,” The American Journal of Human Genetics, vol. 56, no. 2, pp. 528–534, 1995. View at Google Scholar · View at Scopus
  63. N. Rasouli and P. A. Kern, “Adipocytokines and the metabolic complications of obesity,” Journal of Clinical Endocrinology and Metabolism, vol. 93, no. 11, pp. s64–s73, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. H. Sell, C. Habich, and J. Eckel, “Adaptive immunity in obesity and insulin resistance,” Nature Reviews Endocrinology, vol. 8, no. 12, pp. 709–716, 2012. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Mishto, M. L. Raza, D. de Biase et al., “The immunoproteasome beta5i subunit is a key contributor to ictogenesis in a rat model of chronic epilepsy,” Brain, Behavior, and Immunity, vol. 49, pp. 188–196, 2015. View at Publisher · View at Google Scholar
  66. A. M. Ruschak, M. Slassi, L. E. Kay, and A. D. Schimmer, “Novel proteasome inhibitors to overcome bortezomib resistance,” Journal of the National Cancer Institute, vol. 103, no. 13, pp. 1007–1017, 2011. View at Publisher · View at Google Scholar · View at Scopus
  67. D. Chauhan, A. V. Singh, M. Aujay et al., “A novel orally active proteasome inhibitor ONX 0912 triggers in vitro and in vivo cytotoxicity in multiple myeloma,” Blood, vol. 116, no. 23, pp. 4906–4915, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Wehenkel, J.-O. Ban, Y.-K. Ho, K. C. Carmony, J. T. Hong, and K. B. Kim, “A selective inhibitor of the immunoproteasome subunit LMP2 induces apoptosis in PC-3 cells and suppresses tumour growth in nude mice,” British Journal of Cancer, vol. 107, no. 1, pp. 53–62, 2012. View at Publisher · View at Google Scholar · View at Scopus
  69. D. J. Kuhn, S. A. Hunsucker, Q. Chen, P. M. Voorhees, M. Orlowski, and R. Z. Orlowski, “Targeted inhibition of the immunoproteasome is a potent strategy against models of multiple myeloma that overcomes resistance to conventional drugs and nonspecific proteasome inhibitors,” Blood, vol. 113, no. 19, pp. 4667–4676, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. F. Parlati, S. J. Lee, M. Aujay et al., “Carfilzomib can induce tumor cell death through selective inhibition of the chymotrypsin-like activity of the proteasome,” Blood, vol. 114, no. 16, pp. 3439–3447, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. A. F. Baker, N. T. Hanke, B. J. Sands, L. Carbajal, J. L. Anderl, and L. L. Garland, “Carfilzomib demonstrates broad anti-tumor activity in pre-clinical non-small cell and small cell lung cancer models,” Journal of Experimental & Clinical Cancer Research, vol. 33, article 111, 2014. View at Publisher · View at Google Scholar
  72. M. Raule, F. Cerruti, and P. Cascio, “Comparative study of the biochemical properties of proteasomes in domestic animals,” Veterinary Immunology and Immunopathology, vol. 166, no. 1-2, pp. 43–49, 2015. View at Publisher · View at Google Scholar